Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ELUCIREMTM safely and effectively. See full prescribing information for ELUCIREM.ELUCIREMTM (gadopiclenol) injection, for intravenous useInitial U.S. Approval: 2022
Medication labelWhy this: Advisory · dailymed-prescription
ELUCIREM is indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in: the central nervous system (brain, spine, and associated tissues), the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system).
- generic_name
- gadopiclenol
- product_names
- gadopiclenol
- ndc
- 67684-4230, 67684-4232, 67684-4231, 67684-4233, 67684-4240, 67684-4241, 67684-4242, 67684-4250, 67684-4251, 67684-4230-1, 67684-4230-2, 67684-4231-1, 67684-4231-2, 67684-4232-1, 67684-4232-2, 67684-4233-1, 67684-4233-2, 67684-4240-1, 67684-4240-2, 67684-4241-1, 67684-4241-2, 67684-4242-1, 67684-4242-2, 67684-4250-1, 67684-4250-2, 67684-4250-3, 67684-4250-4, 67684-4250-5, 67684-4250-6, 67684-4250-7, 67684-4251-1, 67684-4251-2, 67684-4251-3, 67684-4251-4, 67684-4251-5, 67684-4251-6, 67684-4251-7
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en